George Karavetsos, shareholder in the firm’s FDA group, was featured in the Daily Business Review article, “Buchanan Adds Former FDA Director Amid Increasing Agency Regulation.”
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.